TrialJournal of clinical hypertension (Greenwich, Conn.)2024

Efficacy and safety of combination therapy with telmisartan, rosuvastatin, and ezetimibe in patients with dyslipidemia and hypertension: A randomized, double-blind, multicenter, therapeutic confirmatory, phase III clinical trial.

Chan Joo Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.